FANCM Gene

FANCM Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">FANCM Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>FANCM</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Fanconi Anemia Group M</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>7q22.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>57697</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>609644</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000187240</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q8IWA5</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1252 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~140 kDa</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Ubiquitous (high in proliferating tissues, brain, bone marrow)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Fanconi anemia, breast cancer, AD, PD, ataxia</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">FANCM expression enhancement</td>
<td>Increase FANCM levels via AAV or small molecules</td>
</tr>
<tr>
<td class="label">FA pathway activators</td>
<td>Small molecules that activate FANCD2 monoubiquitination</td>
</tr>
<tr>
<td class="label">Checkpoint inhibition</td>
<td>ATM/ATR inhibitors to promote repair</td>
</tr>
<tr>

FANCM Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">FANCM Gene</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>FANCM</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Fanconi Anemia Group M</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>7q22.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>57697</td>
</tr>
<tr>
<td class="label">OMIM ID</td>
<td>609644</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000187240</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q8IWA5</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1252 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~140 kDa</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>Ubiquitous (high in proliferating tissues, brain, bone marrow)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td>Fanconi anemia, breast cancer, AD, PD, ataxia</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">FANCM expression enhancement</td>
<td>Increase FANCM levels via AAV or small molecules</td>
</tr>
<tr>
<td class="label">FA pathway activators</td>
<td>Small molecules that activate FANCD2 monoubiquitination</td>
</tr>
<tr>
<td class="label">Checkpoint inhibition</td>
<td>ATM/ATR inhibitors to promote repair</td>
</tr>
<tr>
<td class="label">Antioxidants</td>
<td>Reduce oxidative DNA damage burden</td>
</tr>
<tr>
<td class="label">PARP inhibitors</td>
<td>Synthetic lethality with HR defects</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-FANCM delivery</td>
</tr>
<tr>
<td class="label">Target</td>
<td>Compound</td>
</tr>
<tr>
<td class="label">ATM</td>
<td>AZD1390</td>
</tr>
<tr>
<td class="label">ATR</td>
<td>BBI503</td>
</tr>
<tr>
<td class="label">PARP</td>
<td>Olaparib</td>
</tr>
</table>

FANCM (Fanconi Anemia Group M) encodes a DNA translocase and central initiator of the Fanconi anemia (FA) DNA damage response pathway. FANCM plays essential roles in interstrand crosslink (ICL) repair, replication fork remodeling and stabilization, and the maintenance of genomic stability. Loss of FANCM function leads to Fanconi anemia with bone marrow failure and cancer predisposition, while partial deficiency or variants may contribute to neurodegeneration through accumulated DNA damage in post-mitotic [neurons](/entities/neurons)[@meetei2005][@zhang2020].

Overview

Gene Structure

The FANCM gene spans approximately 20 kb on chromosome 7q22.3 and contains 22 exons. The gene encodes a multi-domain protein with DNA translocase activity that serves as the initial sensor of DNA damage in the FA pathway[@meetei2005].

Protein Structure and Function

Domain Architecture

FANCM contains several functional domains[@meetei2005][@gari2008]:

Translocase Activity

FANCM is a DNA translocase that moves along DNA, unwinding secondary structures and detecting damage[@gari2008][@liu2010]:

• Directional movement: FANCM translocates in a 5' to 3' direction relative to the bound strand
• DNA unwinding: ATP-dependent helicase activity unwinds duplex DNA
• Damage detection: Stalls at DNA interstrand crosslinks and other lesions
• Fork remodeling: Can branch migrate replication forks to expose and process ICLs

Normal Physiological Function

Fanconi Anemia Pathway

The FA pathway is the primary mechanism for repairing DNA interstrand crosslinks, which are among the most cytotoxic forms of DNA damage[@meetei2005][@gari2008]:

Replication Fork Remodeling

FANCM remodels stalled replication forks to facilitate ICL repair[@liu2010]:

• Fork stalling: When replisomes encounter ICLs, FANCM is recruited
• Branch migration: FANCM translocase activity pushes the fork forward, remodeling the DNA structure
• Fork protection: FANCM helps prevent excessive fork collapse and generation of toxic DNA breaks
• Checkpoint activation: FANCM signals through ATR/Chk1 to activate cell cycle checkpoints

Genomic Stability Maintenance

FANCM prevents genomic instability through several mechanisms[@wang2018]:

• ICL repair: Primary function in removing interstrand crosslinks from DNA
• Checkpoint signaling: Activates ATM/Chk2 and ATR/Chk1 pathways in response to DNA damage
• Chromosome cohesion: Cooperates with cohesion complexes to maintain chromosome integrity
• Sister chromatid exchange regulation: Controls error-free vs. error-prone repair pathway choice

Disease Associations

Fanconi Anemia

Biallelic FANCM mutations cause Fanconi anemia complementation group M[@meetei2005][@che2019]:

• Bone marrow failure: Progressive pancytopenia due to stem cell attrition
• Congenital abnormalities: Skeletal malformations (radial ray defects), microcephaly, skin pigmentation
• Cancer predisposition: High risk of acute myeloid leukemia, solid tumors (head/neck, gynecological)
• Cellular phenotype: Hypersensitivity to DNA crosslinking agents (mitomycin C, diepoxybutane)
• Phenotype variability: Milder than other FA subtypes due to residual FANCM function

Breast Cancer Susceptibility

FANCM variants modify breast cancer risk[@wang2018]:

• Truncating variants: FANCM nonsense and frameshift variants associated with increased breast cancer risk
• Population studies: Observed in ~1% of population, enriched in breast cancer cases
• Mechanism: Partial loss of FANCM function impairs ICL repair, increasing genomic instability
• Interaction with BRCA: FANCM works in the same pathway as BRCA1/2; variants may synergize

Alzheimer's Disease

FANCM and FA pathway dysfunction contribute to AD through accumulated DNA damage[@zhang2020][@shen2022]:

• Neuronal DNA damage accumulation: Post-mitotic neurons accumulate oxidative and ICL damage over time
• Impaired repair in aging: FA pathway activity declines with age, reducing ICL repair capacity
• Amyloid-beta effects: Aβ induces DNA damage and may impair FA pathway components
• Neurodegeneration mechanism: Unrepaired DNA damage activates apoptosis in neurons
• Therapeutic relevance: Enhancing DNA repair pathways may protect neurons from Aβ toxicity[@shen2022]
• Evidence: FANCM expression is altered in AD brain tissue; pathway components are dysregulated

Parkinson's Disease

DNA repair defects contribute to PD pathogenesis through several mechanisms[@che2019][@zhang2020]:

• Neuronal vulnerability: Dopaminergic neurons in the [substantia nigra](/brain-regions/substantia-nigra) are particularly vulnerable to DNA damage due to high metabolic activity and oxidative stress
• Mitochondrial DNA damage: PD neurons show increased mtDNA mutations; FANCM may affect mtDNA repair
• Alpha-synuclein interactions: DNA damage activates signaling pathways that may promote alpha-synuclein aggregation
• Parkin interaction: The E3 ubiquitin ligase Parkin (PRKN), mutated in familial PD, is involved in DNA damage response
• Aging and PD: Age-related decline in DNA repair capacity is a key contributor to sporadic PD risk
• Animal models: Drosophila models with FANCM deficiency show neurodegeneration and motor dysfunction[@kelsky2021]

Ataxia and Neurological Dysfunction

FANCM variants can cause non-FA neurological presentations:

• Ataxia: Progressive cerebellar ataxia with or without typical FA features
• Neuropathy: Peripheral neuropathy and motor dysfunction
• Cognitive impairment: Learning disabilities and reduced cognitive function
• Mechanism: Partial FANCM deficiency impairs neuronal DNA repair without causing full FA phenotype

Therapeutic Implications

DNA Repair Enhancement

Approaches to enhance FANCM/FA pathway function in neurodegeneration[@shen2022][@zhang2020]:

Clinical Trials in DNA Repair

Neuroprotective Strategies

Specific neuroprotection approaches[@zhang2020][@shen2022]:

• Reduce DNA damage burden: Antioxidants, mitochondrial protectants
• Enhance repair capacity: Increase expression of FA pathway components
• Cell survival signaling: Activate neurotrophic pathways when DNA damage is detected
• Stem cell approaches: FA pathway-enhanced neural stem cells for cell replacement

Animal Models

Fancm Knockout Mice

• Partial lethality: Homozygous knockouts show embryonic or neonatal death in some backgrounds
• FA phenotype: Mitomycin C hypersensitivity, reduced fertility, mild anemia
• Cancer predisposition: Increased tumor formation with age
• Neurodegeneration: Progressive motor deficits and neuronal loss in older mice
• Conditional knockouts: Neuron-specific deletion to study CNS effects

Drosophila Models

Drosophila with FANCM knockdown show[@kelsky2021]:

• Neurodegeneration: Progressive loss of dopaminergic neurons
• Motor dysfunction: Climbing deficits and reduced lifespan
• Genomic instability: Increased DNA damage markers in neurons
• Genetic interactions: Synergy with Parkin and PINK1 mutations
• Rescue by human FANCM: Expression of human FANCM rescues Drosophila phenotype

Disease Models

• Zebrafish Fancm morphants: Developmental abnormalities and DNA repair defects
• Cellular models: FANCM-deficient iPSC-derived neurons show increased DNA damage

Signaling Pathways and Interactions

Protein Interactions

FANCM interacts with multiple FA pathway and DNA repair proteins[@meetei2005][@gari2008]:

• FA core complex: FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL form the core complex recruited by FANCM
• FAAP24: Forms a heterodimer with FANCM, directing it to duplex DNA structures
• FANCD2-FANCI (ID complex): FANCM promotes monoubiquitination of this heterodimer
• ATR-ATRIP: FANCM recruits checkpoint kinase to stalled replication forks
• BLM (Bloom syndrome): FANCM coordinates with BLM helicase in fork processing
• RAD51: FANCM regulates homologous recombination-mediated fork restart

DNA Damage Response

FANCM activates multiple DNA damage response pathways[@zhang2020]:

• ATR/Chk1 pathway: Primary checkpoint for replication stress and ICLs
• ATM/Chk2 pathway: Activated by double-strand breaks from fork collapse
• p53 pathway: Long-term DNA damage leads to p53-mediated cell cycle arrest or apoptosis
• NF-kB pathway: DNA damage activates pro-survival NF-kB signaling

Research Directions

Current Priorities

Key research areas for FANCM include[@zhang2020][@shen2022][@che2019]:

Emerging Questions

• Does FANCM deficiency accelerate Alzheimer's or Parkinson's disease progression?
• Can small molecules enhance FANCM function or FA pathway activity in neurons?
• What is the relative contribution of mitochondrial vs. nuclear DNA damage in neurodegeneration?
• Are there neuroprotective interventions that bypass FANCM deficiency?

Summary

FANCM encodes a DNA translocase that initiates the Fanconi anemia DNA damage response pathway, essential for repairing interstrand crosslinks and maintaining genomic stability. Loss of FANCM causes Fanconi anemia with bone marrow failure and cancer predisposition, while partial deficiency or variants may contribute to Alzheimer's and Parkinson's disease through accumulated DNA damage in vulnerable neurons. Enhancing DNA repair pathways through FANCM or downstream effectors represents a therapeutic strategy to protect neurons from age-related and disease-related DNA damage accumulation.

See Also

• [Fanconi Anemia Pathway](/mechanisms/fanconi-anemia-pathway)
• [DNA Damage Response](/mechanisms/dna-damage-response)
• [DNA Repair and Neurodegeneration](/mechanisms/dna-repair-deficiency-neurodegeneration)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Genomic Instability in Neurodegeneration](/mechanisms/genomic-instability)

External Links

• [FANCM - NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/57697)
• [FANCM Protein - UniProt](https://www.uniprot.org/uniprot/Q8IWA5)
• [FANCM - GeneCards](https://www.genecards.org/cgi-bin/carddisp.pl?gene=FANCM)
• [OMIM: 609644](https://www.omim.org/entry/609644)
• [Ensembl: ENSG00000187240](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000187240)